360 related articles for article (PubMed ID: 17932317)
1. Adiponectin mediates the suppressive effect of rosiglitazone on plasminogen activator inhibitor-1 production.
Hoo RL; Chow WS; Yau MH; Xu A; Tso AW; Tse HF; Fong CH; Tam S; Chan L; Lam KS
Arterioscler Thromb Vasc Biol; 2007 Dec; 27(12):2777-82. PubMed ID: 17932317
[TBL] [Abstract][Full Text] [Related]
2. Plasminogen activator inhibitor-1 modulates adipocyte differentiation.
Liang X; Kanjanabuch T; Mao SL; Hao CM; Tang YW; Declerck PJ; Hasty AH; Wasserman DH; Fogo AB; Ma LJ
Am J Physiol Endocrinol Metab; 2006 Jan; 290(1):E103-E113. PubMed ID: 16144810
[TBL] [Abstract][Full Text] [Related]
3. PPARγ activation induces acute PAI-1 gene expression in the liver but not in adipose tissues of diabetic model mice.
Oishi K; Tomita T; Itoh N; Ohkura N
Thromb Res; 2011 Nov; 128(5):e81-5. PubMed ID: 21757225
[TBL] [Abstract][Full Text] [Related]
4. Dynamic changes of adiponectin and S100A8 levels by the selective peroxisome proliferator-activated receptor-gamma agonist rivoglitazone.
Hiuge-Shimizu A; Maeda N; Hirata A; Nakatsuji H; Nakamura K; Okuno A; Kihara S; Funahashi T; Shimomura I
Arterioscler Thromb Vasc Biol; 2011 Apr; 31(4):792-9. PubMed ID: 21233451
[TBL] [Abstract][Full Text] [Related]
5. Effect of PPAR-gamma agonist on adiponectin levels in the metabolic syndrome: lessons from the high fructose fed rat model.
Sharabi Y; Oron-Herman M; Kamari Y; Avni I; Peleg E; Shabtay Z; Grossman E; Shamiss A
Am J Hypertens; 2007 Feb; 20(2):206-10. PubMed ID: 17261469
[TBL] [Abstract][Full Text] [Related]
6. Aldosterone perturbs adiponectin and PAI-1 expression and secretion in 3T3-L1 adipocytes.
Li P; Zhang XN; Pan CM; Sun F; Zhu DL; Song HD; Chen MD
Horm Metab Res; 2011 Jun; 43(7):464-9. PubMed ID: 21667402
[TBL] [Abstract][Full Text] [Related]
7. Tongqiaohuoxue decoction ameliorates obesity-induced inflammation and the prothrombotic state by regulating adiponectin and plasminogen activator inhibitor-1.
Kim SH; Park HS; Hong MJ; Yoo JY; Lee H; Lee JA; Hur J; Kwon DY; Kim MS
J Ethnopharmacol; 2016 Nov; 192():201-209. PubMed ID: 27404230
[TBL] [Abstract][Full Text] [Related]
8. Rosiglitazone prevents advanced glycation end products-induced renal toxicity likely through suppression of plasminogen activator inhibitor-1.
Yu X; Li C; Li X; Cai L
Toxicol Sci; 2007 Apr; 96(2):346-56. PubMed ID: 17264099
[TBL] [Abstract][Full Text] [Related]
9. Functional significance of skeletal muscle adiponectin production, changes in animal models of obesity and diabetes, and regulation by rosiglitazone treatment.
Liu Y; Chewchuk S; Lavigne C; Brûlé S; Pilon G; Houde V; Xu A; Marette A; Sweeney G
Am J Physiol Endocrinol Metab; 2009 Sep; 297(3):E657-64. PubMed ID: 19531641
[TBL] [Abstract][Full Text] [Related]
10. The PPARgamma ligand, rosiglitazone, reduces vascular oxidative stress and NADPH oxidase expression in diabetic mice.
Hwang J; Kleinhenz DJ; Rupnow HL; Campbell AG; Thulé PM; Sutliff RL; Hart CM
Vascul Pharmacol; 2007 Jun; 46(6):456-62. PubMed ID: 17337254
[TBL] [Abstract][Full Text] [Related]
11. Adipose mitochondrial biogenesis is suppressed in db/db and high-fat diet-fed mice and improved by rosiglitazone.
Rong JX; Qiu Y; Hansen MK; Zhu L; Zhang V; Xie M; Okamoto Y; Mattie MD; Higashiyama H; Asano S; Strum JC; Ryan TE
Diabetes; 2007 Jul; 56(7):1751-60. PubMed ID: 17456854
[TBL] [Abstract][Full Text] [Related]
12. Cilostazol ameliorates metabolic abnormalities with suppression of proinflammatory markers in a db/db mouse model of type 2 diabetes via activation of peroxisome proliferator-activated receptor gamma transcription.
Park SY; Shin HK; Lee JH; Kim CD; Lee WS; Rhim BY; Hong KW
J Pharmacol Exp Ther; 2009 May; 329(2):571-9. PubMed ID: 19221061
[TBL] [Abstract][Full Text] [Related]
13. N-acetylcysteine attenuates TNF-alpha induced changes in secretion of interleukin-6, plasminogen activator inhibitor-1 and adiponectin from 3T3-L1 adipocytes.
Araki S; Dobashi K; Kubo K; Yamamoto Y; Asayama K; Shirahata A
Life Sci; 2006 Nov; 79(25):2405-12. PubMed ID: 16952378
[TBL] [Abstract][Full Text] [Related]
14. Effect of PPAR-alpha and -gamma agonist on the expression of visfatin, adiponectin, and TNF-alpha in visceral fat of OLETF rats.
Choi KC; Ryu OH; Lee KW; Kim HY; Seo JA; Kim SG; Kim NH; Choi DS; Baik SH; Choi KM
Biochem Biophys Res Commun; 2005 Oct; 336(3):747-53. PubMed ID: 16157299
[TBL] [Abstract][Full Text] [Related]
15. Intermittent high glucose stimulate MCP-l, IL-18, and PAI-1, but inhibit adiponectin expression and secretion in adipocytes dependent of ROS.
Sun J; Xu Y; Dai Z; Sun Y
Cell Biochem Biophys; 2009; 55(3):173-80. PubMed ID: 19756411
[TBL] [Abstract][Full Text] [Related]
16. Soluble CD40 ligand, plasminogen activator inhibitor-1 and thrombin-activatable fibrinolysis inhibitor-1-antigen in normotensive type 2 diabetic subjects without diabetic complications. Effects of metformin and rosiglitazone.
Yener S; Comlekci A; Akinci B; Demir T; Yuksel F; Ozcan MA; Bayraktar F; Yesil S
Med Princ Pract; 2009; 18(4):266-71. PubMed ID: 19494532
[TBL] [Abstract][Full Text] [Related]
17. Combined effects of rosiglitazone and conjugated linoleic acid on adiposity, insulin sensitivity, and hepatic steatosis in high-fat-fed mice.
Liu LF; Purushotham A; Wendel AA; Belury MA
Am J Physiol Gastrointest Liver Physiol; 2007 Jun; 292(6):G1671-82. PubMed ID: 17322064
[TBL] [Abstract][Full Text] [Related]
18. A novel selective peroxisome proliferator-activator receptor-gamma modulator-SPPARgammaM5 improves insulin sensitivity with diminished adverse cardiovascular effects.
Chang CH; McNamara LA; Wu MS; Muise ES; Tan Y; Wood HB; Meinke PT; Thompson JR; Doebber TW; Berger JP; McCann ME
Eur J Pharmacol; 2008 Apr; 584(1):192-201. PubMed ID: 18346728
[TBL] [Abstract][Full Text] [Related]
19. Metformin, but not thiazolidinediones, inhibits plasminogen activator inhibitor-1 production in human adipose tissue in vitro.
He G; Pedersen SB; Bruun JM; Lihn AS; Richelsen B
Horm Metab Res; 2003 Jan; 35(1):18-23. PubMed ID: 12669266
[TBL] [Abstract][Full Text] [Related]
20. 5-Hydroxytryptamine 2A receptor signaling cascade modulates adiponectin and plasminogen activator inhibitor 1 expression in adipose tissue.
Uchida-Kitajima S; Yamauchi T; Takashina Y; Okada-Iwabu M; Iwabu M; Ueki K; Kadowaki T
FEBS Lett; 2008 Sep; 582(20):3037-44. PubMed ID: 18675814
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
